MedTrace Logo

Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients

NCT00778063 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-04-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium during general sevoflurane anesthesia in a pediatric population receiving pressure equalization tubes in one or more ear.

Conditions

  • Otitis Media

Interventions

DRUG

dexmedetomidine

2 mcg/kg intranasally 30 minutes prior to surgery

DRUG

saline

a volume of intranasal saline, calculated based on body weight, will be given 30 minutes prior to surgery

Sponsors & Collaborators

  • Ochsner Health System

    lead OTHER

Principal Investigators

  • Usha Ramadhyani, MD · Ochsner Health System

  • Dominic S Carollo, MD · Ochsner Health System

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00778063 on ClinicalTrials.gov